The Expression of GPRC5A in Cultured Normal and Malignant Cells is Modulated by Endogenous Retinoids in Serum

Xiaofeng Ye,Jiong Deng,Dafna Lotan,Reuben Lotan

IF: 11.2

2007-01-01

Cancer Research

Abstract:1652 GPRC5A, a gene that encodes a retinoic acid (RA) inducible G protein coupled receptor (Cheng and Lotan, J Biol Chem, 1998, 273:35008-15), is a candidate tumor suppressor in the mouse lung (Tao et al., Proc. AACR, 2004, 45: 876). The presence of a RA response element in its promoter (Tao et al., Genomics, 2004, 83:270-80) suggests that GPRC5A is a primary target of retinoids and could mediate some of their effects on cell growth, differentiation and apoptosis. Wu et al. reported that the GPRC5A expression is up regulated in several tumor cell lines including non-small cell lung cancer (NSCLC) cell lines than in normal cells (J Biol Chem, 2005, 280: 12935-43). These results contradicted our observation that GPRC5A expression was high in normal lung tissue and decreased in NSCLC cell lines (Cheng and Lotan, 1998). Because primary cultures of normal epithelial cells are usually grown in serum-free medium, whereas tumor cells are cultured in medium supplemented with 10% serum (e.g., fetal bovine), we hypothesized that the differential expression of GPRC5A observed by Wu et al., may have occurred due to the presence of endogenous retinoids in the growth medium of the tumor cells but not of their normal counterparts. To test this hypothesis, we analyzed GPRC5A expression by real-time PCR using RNA isolated from different human primary cell strains and established cancer cell lines that were all cultured without or with 10% fetal bovine serum. The primary and low passage normal cell strains included cells derived from lung (n=9), breast (n=3), prostate (n=2), oral gingiva (n=1), and bladder (n=1). The established cancer cell lines included NSCLC (n=11), breast (n=9), head and neck squamous cell carcinomas (n=6), prostate (n=3), and bladder carcinomas (n=5). We found that GPRC5A was induced to some degree in 44/50 (88%) of these cells, and >2 fold in 34/50 (68%) of these cells when they were cultured with serum compared with serum-free medium. In most cases, the fold induction by serum and the induced levels of GPRC5A in the normal cells was higher than in their corresponding cancer cells. Further studies with 7 normal lung cells and 2 normal breast cell strains revealed that AGN193109, an antagonist of retinoic acid receptors, suppressed the induction of GPRC5A by serum as evident by real time- and reverse-transcription PCR. Our results demonstrate that GPRC5A expression can be induced by endogenous serum retinoids in both normal and malignant human cells and that a comparison of the expression of this and likely other genes between normal and malignant cells should be performed under the same culture conditions and medium supplements (e.g., serum) to avoid reaching potentially erroneous conclusions (e.g., that the expression of certain genes is increased in tumor cells relative to normal cells when such genes may be regulated by serum retinoids). Supported in part by Department of Defense grant DAMD W81XWH-04-1-0142.